Pfizer INC (PFE) Stock Price Rose While Huntington National Bank Lowered Its Stake

November 10, 2018 - By Ellis Scott

Pfizer Inc. (NYSE:PFE) LogoInvestors sentiment decreased to 0.78 in Q2 2018. Its down 0.11, from 0.89 in 2018Q1. It turned negative, as 52 investors sold PFE shares while 754 reduced holdings. 112 funds opened positions while 518 raised stakes. 3.98 billion shares or 0.73% less from 4.01 billion shares in 2018Q1 were reported. Trustmark Bank & Trust Department has 124,529 shares for 0.53% of their portfolio. Advisor Ptnrs Limited Company reported 150,279 shares. Signature Est & Inv Limited Co, California-based fund reported 4,071 shares. Bragg Advsr Incorporated holds 0.86% or 165,511 shares. Amer Economic Planning Group Inc Adv invested 0.23% in Pfizer Inc. (NYSE:PFE). Hays Advisory Limited Co reported 0.13% of its portfolio in Pfizer Inc. (NYSE:PFE). 25,749 were accumulated by Quantum. Jpmorgan Chase Communication stated it has 0.81% in Pfizer Inc. (NYSE:PFE). Ameriprise Finance reported 55.11M shares or 0.88% of all its holdings. Cincinnati reported 3.24 million shares. 186,491 are owned by Cna Fin Corporation. The New York-based Joel Isaacson And Ltd Liability Company has invested 0.24% in Pfizer Inc. (NYSE:PFE). Vaughan Nelson Mgmt L P, a Texas-based fund reported 35,250 shares. One Cap Mngmt Ltd Liability has 0.67% invested in Pfizer Inc. (NYSE:PFE). Greatmark Invest Prtn Inc holds 0.07% or 5,638 shares in its portfolio.

Since June 4, 2018, it had 0 buys, and 4 selling transactions for $2.80 million activity. CORNWELL W DON had sold 5,223 shares worth $190,117 on Monday, June 4. 40,381 Pfizer Inc. (NYSE:PFE) shares with value of $1.50 million were sold by SUSMAN SALLY.

Huntington National Bank decreased its stake in Pfizer Inc (PFE) by 7.79% based on its latest 2018Q2 regulatory filing with the SEC. Huntington National Bank sold 131,252 shares as the company’s stock rose 17.09% with the market. The institutional investor held 1.55M shares of the health care company at the end of 2018Q2, valued at $56.34 million, down from 1.68 million at the end of the previous reported quarter. Huntington National Bank who had been investing in Pfizer Inc for a number of months, seems to be less bullish one the $259.57B market cap company. The stock increased 0.98% or $0.43 during the last trading session, reaching $44.28. About 24.71M shares traded or 15.16% up from the average. Pfizer Inc. (NYSE:PFE) has risen 19.90% since November 10, 2017 and is uptrending. It has outperformed by 4.28% the S&P500.

Huntington National Bank, which manages about $6.02 billion US Long portfolio, upped its stake in Anthem Inc (NYSE:ANTM) by 37,627 shares to 49,511 shares, valued at $11.79 million in 2018Q2, according to the filing. It also increased its holding in Edwards Lifesciences Corp (NYSE:EW) by 25,027 shares in the quarter, for a total of 213,727 shares, and has risen its stake in Amazon.Com Inc (NASDAQ:AMZN).

More notable recent Pfizer Inc. (NYSE:PFE) news were published by: Seekingalpha.com which released: “Evaluating Pfizer’s Growth Plans And Valuation” on November 01, 2018, also Seekingalpha.com with their article: “Pfizer (PFE) Q3 2018 Results – Earnings Call Transcript” published on October 30, 2018, Seekingalpha.com published: “FDA OKs Pfizer’s lorlatinib for lung cancer” on November 02, 2018. More interesting news about Pfizer Inc. (NYSE:PFE) were released by: Seekingalpha.com and their article: “Premarket analyst action – healthcare” published on November 01, 2018 as well as Benzinga.com‘s news article titled: “BMO Downgrades Pfizer After Q3 Print, Says Risk-Reward ‘Fairly Balanced'” with publication date: November 01, 2018.

Pfizer Inc. (NYSE:PFE) Ratings Coverage

Among 7 analysts covering Pfizer (NYSE:PFE), 3 have Buy rating, 1 Sell and 3 Hold. Therefore 43% are positive. Pfizer has $4500 highest and $37 lowest target. $42.29’s average target is -4.49% below currents $44.28 stock price. Pfizer had 9 analyst reports since June 7, 2018 according to SRatingsIntel. The rating was initiated by Cantor Fitzgerald on Thursday, June 7 with “Buy”. The stock of Pfizer Inc. (NYSE:PFE) earned “Neutral” rating by Credit Suisse on Wednesday, October 31. The rating was downgraded by BMO Capital Markets to “Market Perform” on Thursday, November 1. The stock has “Outperform” rating by BMO Capital Markets on Wednesday, August 1. Bank of America maintained Pfizer Inc. (NYSE:PFE) on Wednesday, August 1 with “Buy” rating. Citigroup maintained the stock with “Sell” rating in Tuesday, November 6 report. As per Wednesday, August 1, the company rating was maintained by Credit Suisse. The firm has “Overweight” rating by Morgan Stanley given on Thursday, August 23. Barclays Capital maintained Pfizer Inc. (NYSE:PFE) on Thursday, August 23 with “Equal-Weight” rating.

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>